Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

Preferential transmission and association of the −403 G → A promoter RANTES polymorphism with atopic asthma

Abstract

Asthma is a complex inherited disease. The study was undertaken to identify the association of RANTES promoter polymorphisms with atopy and asthma using family-based association tests (FBATs) and generation-specific case–control analyses. We identified 154 nuclear families (453 individuals) in whom we established RANTES promoter status using the RFLP-PCR method. Of the two known promoter polymorphisms −403G/A and −28C/G, only the former appeared with a clinically relevant frequency. A total of 61 families were eligible for assessment of transmission of the allele with asthma and atopy by the pedigree disequilibrium test (PDT). Overall, allele frequency for −403A was 38.3% and 84 of 89 (94.3%) alleles were transmitted with physician diagnosed asthma (PDA) (P=0.001). All 89 children with atopy received the mutant allele, which was more than expected following Mendelian Laws of transmission (P=0.0001). In 303 unrelated parents, significant associations of the mutant allele were for atopy with or without asthma (P=0.001). In 150 unrelated children, significant associations were for atopy alone (P=0.001) and asthma (P=0.001). No associations were found for bronchial hyper-responsiveness (BHR). The −403 G → A is transmitted with atopy and atopic asthma, although its contribution appears to relate more to atopy than asthma and BHR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Milos F, Snezana C . The role of eosinophils in asthma. Med Biol 2001; 8: 6–10.

    Google Scholar 

  2. Cantani A, Herrera RJ, Cameron C . Respiratory symptoms and lung function in relation to atopy in children. J Allergy Clin Immunol 1999; 6: 305–309.

    Google Scholar 

  3. Settipane RJ, Calvani M, Alessandri C et al. Asthma in childhood. Eur J Immunogenet 1994; 6: 124–131.

    Google Scholar 

  4. Teran LM, Noso N, Carroll M, Davies DE, Holgate S, Schroder JM . Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996; 157: 1806–1812.

    CAS  PubMed  Google Scholar 

  5. Conti P, Barbacane RC, Reale M . Chemokines in inflammatory states. Allergy Asthma Proc 1999; 20: 205–208.

    Article  CAS  PubMed  Google Scholar 

  6. Chihara J, Yasuba H, Tsuda A et al. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997; 100: S52–S55.

    Article  CAS  PubMed  Google Scholar 

  7. Schuh JM, Blease K, Hogaboam CM . The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J 2002; 16: 228–230.

    Article  CAS  PubMed  Google Scholar 

  8. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P . Identification of RANTES, MIP-1-alpha, and MIP-1-beta as the major HIV suppressive factors produced by CD8(+) T cells. Science 1995; 270: 1811–1815.

    Article  CAS  PubMed  Google Scholar 

  9. Cookson WO . A new gene for asthma: would you ADAM and Eve it? Trends Genet 2003; 19: 169–172.

    Article  CAS  PubMed  Google Scholar 

  10. Makki RF, al Sharif F, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE, Hajeer AH . RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 391–393.

    CAS  PubMed  Google Scholar 

  11. Liu H, Chao D, Nakayama EE et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581–4585.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M . A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Resp Crit Care Med 2002; 166: 686–690.

    Article  PubMed  Google Scholar 

  13. al Sharif F, Ollier WE, Hajeer AH . A rare polymorphism at position −28 in the human RANTES promoter. Eur J Immunogenet 1999; 26: 373–374.

    Article  CAS  PubMed  Google Scholar 

  14. Hajeer AH, al Sharif F, Ollier WE . A polymorphism at position—403 in the human RANTES promoter. Eur J Immunogenet 1999; 26: 375–376.

    Article  CAS  PubMed  Google Scholar 

  15. Weiss MJ, Orkin SH . GATA-transcription factors: key regulators of hematopoiesis. Exp Hematol 1995; 23: 99–107.

    CAS  PubMed  Google Scholar 

  16. Fryer AA, Spiteri MA, Bianco A et al. The −403G → A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000; 1: 509–514.

    Article  CAS  PubMed  Google Scholar 

  17. Yao TC, Kuo ML, See LC et al. The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 2003; 111: 1285–1292.

    Article  CAS  PubMed  Google Scholar 

  18. Schall TJ, Bacon K, Toy KJ, Goeddel DV . Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669–671.

    Article  CAS  PubMed  Google Scholar 

  19. Marine J, Winoto A . The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc Natl Acad Sci USA 1991; 88: 7284–7288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Liu H, Chao D, Nakayama E et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581–4585.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gauvreau GM, Watson RM, O’Byrne PM . Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Resp Crit Care Med 1999; 160: 640–647.

    Article  CAS  PubMed  Google Scholar 

  22. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM . Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587–592.

    Article  CAS  PubMed  Google Scholar 

  23. Gonzalez E, Dhanda R, Bamshad M et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001; 98: 5199–5204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nickel RG, Casolaro V, Wahn U et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000; 164: 1612–1616.

    Article  CAS  PubMed  Google Scholar 

  25. Dawson B, Horobin G, Illsley R, Mitchell R . A survey of childhood asthma in Aberdeen. Lancet 1969; 1: 827–830.

    Article  CAS  PubMed  Google Scholar 

  26. Christie GL, Helms PJ, Godden DJ et al. Asthma, wheezy bronchitis, and atopy across two generations. Am J Resp Crit Care Med 1999; 159: 125–129.

    Article  CAS  PubMed  Google Scholar 

  27. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE . Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235–243.

    Article  CAS  PubMed  Google Scholar 

  28. Crapo RO, Morris AH, Gardner RM . Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Resp Dis 1981; 123: 659–664.

    CAS  PubMed  Google Scholar 

  29. Wang XB, Dockery DW, Wypij D Fay ME, Ferris BG . Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 5: 75–88.

    Article  Google Scholar 

  30. Quadt K, Frech K, Karas H, Wingender E, Werner T . Matlnd and Matinspector: new fast and versatile tools for detecting of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878–4884.

    Article  Google Scholar 

  31. Eriksson S, Berg L, Wadelius M, Alderborn A . Cytochrome P450 genotyping by multiplexed real-time DNA sequencing with pyrosequencing™ technology. Assay Drug Dev Technol 2002; 1: 49–59.

    Article  CAS  PubMed  Google Scholar 

  32. Martin ER, Monks SA, Warren LL, Kaplan NL . A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146–154.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Martin ER, Bass MP, Kaplan NL . Correcting for potential bias in the pedigree disequilibrium test. Am J Hum Genet 2001; 68: 1065–1067.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

GlaxoSmithKline Research and development and the Scottish Heart Chest and Stroke Association supported the family collection. We thank Julie Black and Joanna Gordon for valuable assistant in family recruitment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S A Al-Abdulhadi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Abdulhadi, S., Helms, P., Main, M. et al. Preferential transmission and association of the −403 G → A promoter RANTES polymorphism with atopic asthma. Genes Immun 6, 24–30 (2005). https://doi.org/10.1038/sj.gene.6364151

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364151

Keywords

This article is cited by

Search

Quick links